Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Completed

Abbott Diabetes Care, Inc. recalls FreeStyle Libre 3 App

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
Products
  • FreeStyle Libre 3 App
Where it was sold

US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.

States: California, Florida, Iowa, Indiana, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, North Carolina, Nebraska, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Utah, Virginia

Barcodes
00357599816001
Units affected
45,173
About this recall
FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System